Actively Recruiting

Age: 18Years - 55Years
All Genders
NCT06435611

Adiposity, Cardiometabolic and Neurocognitive Health Among Ethnic Groups: a Feasibility and Pilot Study

Led by King's College Hospital NHS Trust · Updated on 2024-05-30

10

Participants Needed

2

Research Sites

32 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this pilot and feasibility study is to is to test the feasibility of conducting a cross-sectional study on adiposity and cardiometabolic and neurocognitive risk factors at Kings College Hospital NHS Foundation Trust (KCH). The main aim is to assess and compare anthropometric measurements of adiposity (weight, Body Mass Index (BMI), Waist Circumference (WC), Waist-to-Hip ratio (WHR), Neck circumference (NC)), liver fat (hepatic steatosis and fibrosis), cardiometabolic risk factors (dyslipidemia, insulin resistance, hypertension) and neurocognitive risk factors among participants, according to their ethnic background. Participants will come at KCH for one visit and will have their anthropometric measurements and cardio-metabolic profile assessed. They will also perform questionnaires on lifestyle, socio-economic status and neuro-cognitive health during their visit.

CONDITIONS

Official Title

Adiposity, Cardiometabolic and Neurocognitive Health Among Ethnic Groups: a Feasibility and Pilot Study

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women aged 18 years or older
  • Body mass index (BMI) of 30 kg/m2 or higher
Not Eligible

You will not qualify if you...

  • Severe obesity with BMI greater than 50 kg/m2
  • Pregnancy or recent pregnancy within the past 6 months
  • Known active chronic liver diseases
  • Known diagnosis of human immunodeficiency virus (HIV)
  • Advanced renal failure with estimated Glomerular Filtration Rate (eGFR) less than 30 ml/min
  • Diagnosis of decompensated heart failure
  • History of bariatric surgery
  • Uncontrolled thyroid disease
  • Current use of steroids (oral or injections only), weight-loss medication including over-the-counter products, GLP-1 agonists, or SGLT2 inhibitors

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

King's College Hospital NHS Foundation Trust

London, United Kingdom of Great Britain and Northern Ireland, United Kingdom, SE5 9RS

Active, Not Recruiting

2

King's College Hospital NHS Foundation Trust

London, United Kingdom, SE5 9RS

Actively Recruiting

Loading map...

Research Team

F

Fannie Lajeunesse-Trempe, MD, Msc

CONTACT

G

Georgios K. Dimitriadis, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here